{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:50:10Z","timestamp":1758970210531},"reference-count":33,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1507\/endocrj.k07e-027","type":"journal-article","created":{"date-parts":[[2008,3,18]],"date-time":"2008-03-18T05:51:04Z","timestamp":1205819464000},"page":"127-134","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of Combined Treatment with Raloxifene and Alfacalcidol on Bone Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis"],"prefix":"10.1507","volume":"55","author":[{"given":"Takafumi","family":"MAJIMA","sequence":"first","affiliation":[{"name":"Division of Metabolic Research, Clinical Research Institute, Center for Endocrine and Metabolic Diseases, National Hospital Organization, Kyoto Medical Center"},{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine"},{"name":"Department of Endocrinology and Metabolism, Rakuwakai Otowa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasato","family":"KOMATSU","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"SHIMATSU","sequence":"additional","affiliation":[{"name":"Division of Metabolic Research, Clinical Research Institute, Center for Endocrine and Metabolic Diseases, National Hospital Organization, Kyoto Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"SATOH","sequence":"additional","affiliation":[{"name":"Division of Metabolic Research, Clinical Research Institute, Center for Endocrine and Metabolic Diseases, National Hospital Organization, Kyoto Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"FUKAO","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine, Rakuwakai Otowa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"NINOMIYA","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Rakuwakai Otowa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"MATSUMURA","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Rakuwakai Otowa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuwa","family":"NAKAO","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.7.637"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-003-1424-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Delmas PD, Bjarnason NH, Mitlak BH, <i>et al.<\/i> (1997) Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 337: 1641-1647.","DOI":"10.1056\/NEJM199712043372301"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Johnston CC Jr, Bjarnason NH, Cohen FJ, <i>et al.<\/i> (2000) Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials. Arch Intern Med 160: 3444-3450.","DOI":"10.1001\/archinte.160.22.3444"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-005-0028-3"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050509"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1007\/s007740050102"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Iwamoto J, Takeda T, Sato Y (2006) Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis. Curr Med Res Opin 22: 919-928.","DOI":"10.1185\/030079906X100276"},{"issue":"4","key":"9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00774-004-0494-2","volume":"22","author":"SHIRAKI M","year":"2004","ISSN":"http:\/\/id.crossref.org\/issn\/0914-8779","issn-type":"print"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1007\/BF00305521"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.43.211"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050214"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050131"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tilyard MW, Spears GF, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326: 357-362.","DOI":"10.1056\/NEJM199202063260601"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Richy F, Ethgen O, Bruyere O, Reginster JY (2004) Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int 15: 301-310.","DOI":"10.1007\/s00198-003-1570-5"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.89.255"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ushiroyama T, Ikeda A, Ueki M (2002) Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas 41: 211-221.","DOI":"10.1016\/S0378-5122(01)00275-4"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1007\/s007760070003"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1007\/s007740170001"},{"key":"20","unstructured":"20. Higashi S, Shiraishi A, Hayakawa N, Kubota N (2004) Effects of raloxifene on vertebrae; Efficacy and safety of combined therapy of raloxifene and alphacalcidol. Med Drug J 40: 156-162."},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.1.1"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.0301243"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.4.770"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Adami S, Kanis JA (1995) Perspectives: Assessment of involutional bone loss: Methodological and conceptual problems. J Bone Miner Res 10: 511-517.","DOI":"10.1002\/jbmr.5650100402"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Gatti D, Viapiana O, Lippolis I, <i>et al.<\/i> (2005) Intravenous bisphosphonate therapy increases radial width in adults with osteogenesis imperfecta. J Bone Miner Res 20: 1323-1326.","DOI":"10.1359\/JBMR.050312"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Gorai I, Chaki O, Taguchi Y, <i>et al.<\/i> (1999) Early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D<sub>3<\/sub>: therapeutic effects of estrogen and\/or 1alpha-OH-vitamin D<sub>3<\/sub>. Calcif Tissue Int 65: 16-22.","DOI":"10.1007\/s002239900651"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Gallagher JC, Fowler SE, Detter JR, Sherman SS (2001) Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 86: 3618-3628.","DOI":"10.1210\/jcem.86.8.7703"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.2.546"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-005-0639-y"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Antoniucci DM, Vittinghoff E, Blackwell T, Black DM, Sellmeyer DE (2005) Vitamin D insufficiency does not affect bone mineral density response to raloxifene. J Clin Endocrinol Metab 90: 4566-4572.","DOI":"10.1210\/jc.2005-0290"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)01124-X"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.3.985"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Lind L, Lithell H, Wengle B, Wrege U, Ljunghall S (1988) A pilot study of metabolic effects of intravenously given alpha-calcidol in patients with chronic renal failure. Scand J Urol Nephrol 22: 219-222.","DOI":"10.1080\/00365599.1988.11690415"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/55\/1\/55_K07E-027\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:46:50Z","timestamp":1618296410000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/55\/1\/55_K07E-027\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k07e-027","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}